What is the GMP of Accretion Nutraveda IPO today?

The Grey Market Premium (GMP) for Accretion Nutraveda IPO is currently ₹16. With an upper price band of ₹129, the estimated listing price is ₹145 per share, reflecting an expected listing gain of ~12.40%. Grey market premiums can fluctuate based on market sentiment and subscription demand.

What is the price band and lot size for Accretion Nutraveda IPO?

The price band for Accretion Nutraveda IPO is ₹122 to ₹129 per equity share. The minimum lot size is 1000 shares, which requires a minimum retail application investment of ₹1,29,000.

What are the important dates for Accretion Nutraveda IPO?

Accretion Nutraveda IPO opens for subscription on 2026-01-28T00:00:00 and closes on 2026-01-30T00:00:00. The basis of allotment is scheduled for 2026-02-02T00:00:00, and shares are expected to list on 2026-02-04T00:00:00 on BSE, NSE.

How can I check the allotment status for Accretion Nutraveda IPO?

You can check Accretion Nutraveda IPO allotment status on the registrar's official portal (KFin Technologies Limited) or through the official BSE and NSE IPO allotment status pages using your PAN number or Application number.

How to apply for Accretion Nutraveda IPO?

Investors can apply for Accretion Nutraveda IPO online through ASBA (Application Supported by Blocked Amount) via their internet banking account, or via UPI using authorized stockbroking platforms like Zerodha, Groww, Angel One, and Upstox.

When does the Accretion Nutraveda IPO open and close?

The IPO opens on 28 Jan 2026, and closes on 30 Jan 2026.

What is Accretion Nutraveda IPO price band?

The issue price band is ₹122.00 to ₹129.00 per equity share.

What is the Accretion Nutraveda IPO lot size?

The minimum lot size is 1000 shares per application.

What is the Accretion Nutraveda IPO allotment date?

The allotment is scheduled on 2 Feb 2026.

Accretion Nutraveda IPO Details - Dates, Price Band, Issue Size

All IPOs

Issue Size

25.00 Cr

Price Band

₹122.00 - ₹129.00

Lot Size

1000 Shares

Min Investment

₹2,58,000

GMP

₹16

Subscription

1.83x

₹30.24 Cr

28 Jan 2026

IPO Opens

COMPLETED

30 Jan 2026

IPO Closes

COMPLETED

02 Feb 2026

Basis of Allotment

COMPLETED

03 Feb 2026

Refunds

COMPLETED

03 Feb 2026

Demat Credit

COMPLETED

04 Feb 2026

Listing

COMPLETED

IPO Timeline

IPO OpensDONE

28 Jan 2026

IPO ClosesDONE

30 Jan 2026

Basis of AllotmentDONE

02 Feb 2026

RefundsDONE

03 Feb 2026

Demat CreditDONE

03 Feb 2026

ListingDONE

04 Feb 2026

About Accretion Nutraveda IPO

Accretion Nutraveda IPO open date is January 28, 2026 and the IPO will close on January 30, 2026. Accretion Nutraveda IPO is a Book Build Issue. The company to raise around ₹24.77 crores via IPO that comprises fresh issue of ₹24.77 crores and offer for sale up to [.] equity shares with face value of ₹10 each.

Accretion Nutraveda IPO price band is ₹122 to ₹129 per share. The retail quota is 35%, QIB is 50%, and HNI is 15%. Accretion Nutraveda IPO to list on BSE SME on February 4, 2026. The allotment of Accretion Nutraveda IPO date is February 2, 2026.

The company reported revenue of ₹16.06 crores in 2025 against ₹5.20 crores in 2024. The company reported profit of ₹2.61 crores in 2025 against profit of ₹0.82 crores in 2024. As per the financials the IPO investors should apply the IPO for a long term.

IPO Details

Accretion Nutraveda IPO Details and Specifications
IPO Date	28 Jan 2026 to 30 Jan 2026
Face Value	₹10 Per Share
Price Band	₹122.00 - ₹129.00
Lot Size	1000 Shares
Total Issue Size	Approx 25.00 Cr 19,20,000 Equity Shares
Fresh Issue	Approx 25.00 Cr 19,20,000 Equity Shares
Offer for Sale	Approx 0.00 Cr 0 Equity Shares
Retail Portion	35.09%
Sale Type	Fresh Issue
Issue Type	Bookbuilding IPO
Listing Date	04 Feb 2026
Listing At	BSE
Total Subscription Amount	₹30.24 Cr

Issue Reservation

Investor Category	Shares Offered	% Net Issue
QIB	9,08,000	49.78%
- Anchor	5,44,000	0.00%
- QIB (Ex. Anchor)	3,64,000	0.00%
NII	2,76,000	15.13%
- bNII > ₹10L	1,84,000	0.00%
- sNII < ₹10L	92,000	0.00%
Retail	6,40,000	35.09%
Total	18,24,000	100.00%

IPO Lot Size

Application	Lots	Shares	Amount
Individual investors (Retail) (Min)	2	2,000	₹2,58,000
Individual investors (Retail) (Max)	2	2,000	₹2,58,000
S-HNI (Min)	3	3,000	₹3,87,000
S-HNI (Max)	7	7,000	₹9,03,000
B-HNI (Min)	8	8,000	₹10,32,000

About Company

Accretion Nutraveda, since its incorporation in 2021, has been focused on the manufacturing of Ayurvedic and Nutraceutical products in India. It offers Ayurvedic and Nutraceutical products in various dosages and forms, like tablets, capsules, oral liquids, powders, oils, and external preparations like balms, creams, and gels.

The company serves its customers in India as well as in international countries like Sri Lanka, Singapore, and the USA. The firm blends Ayurvedic and science to offer treatments for various areas, like liver care, women’s health, bone and joint health, cognitive support, and respiratory wellness. The company runs a 10,763 sq. ft. manufacturing facility situated in Gujarat. Its unit includes modern infrastructure and quality control systems.

Contact Details

Accretion Nutraveda Ltd.

27 Xcelon Industrial Park-1

Vasna-Chacharwadi, TaSanand,

Ahmedabad, Gujarat, 382213

+91- 9904366177

compliance@accretionnutraveda.com

Visit Website

Registrar

KFin Technologies Limited

04067162222, 04

apl.ipo@kfintech.com

Lead Managers

Sobhagya Capital Options Ltd

Day-wise GMP Trend

Date & Time	GMP (₹)	Est. Listing Price	Est. Gain (%)	Est. Profit / Lot (₹)
04-Feb-2026 12:00 AM	+₹16	₹145	+12.40%	₹16,000
03-Feb-2026 12:00 AM	+₹16	₹145	+12.40%	₹16,000
02-Feb-2026 12:00 AM	+₹6	₹135	+4.65%	₹6,000
01-Feb-2026 12:00 AM	+₹4	₹133	+3.10%	₹4,000
31-Jan-2026 12:00 AM	+₹4	₹133	+3.10%	₹4,000
30-Jan-2026 05:05 PM	+₹0	₹129	+0.00%	₹0
29-Jan-2026 02:45 PM	+₹0	₹129	+0.00%	₹0
28-Jan-2026 03:45 PM	+₹0	₹129	+0.00%	₹0
27-Jan-2026 03:45 PM	+₹0	₹129	+0.00%	₹0
26-Jan-2026 01:00 PM	+₹0	₹129	+0.00%	₹0
24-Jan-2026 03:45 PM	+₹0	₹129	+0.00%	₹0
23-Jan-2026 02:52 PM	+₹0	₹129	+0.00%	₹0
22-Jan-2026 03:45 PM	+₹0	₹129	+0.00%	₹0
21-Jan-2026 03:45 PM	+₹0	₹129	+0.00%	₹0
20-Jan-2026 03:45 PM	+₹0	₹129	+0.00%	₹0

Subscription Status

Category	Subscription (x)	Shares Offered	Shares bid for	Total Amount (₹ Cr)
QIB (Ex. Anchor)	1.01x	3,64,000	3,67,000	₹4.73 Cr
NII	2.08x	2,76,000	5,73,000	₹7.39 Cr
bNII > ₹10L	1.30x	1,84,000	3,59,000	₹4.63 Cr
sNII < ₹10L	2.33x	92,000	2,14,000	₹2.76 Cr
Retail	2.19x	6,40,000	14,04,000	₹18.11 Cr
Total	1.83x	12,80,000	23,44,000	₹30.24 Cr

Objects of the Issue

01 Purchase of Machineries for Automation in existing Manufacturing unit : 4.22 Cr
02 Purchase of Machineries for New Manufacturing Setup : 8.03 Cr
03 Funding working capital requirements of our company : 5.50 Cr
04 General Corporate Purpose : 3.69 Cr
05 Issue Expenses : 3.33 Cr

Company Financials

Period Ended	30 SEPT 2025	31 MAR 2025	31 MAR 2024
Total Income	14.07	16.06	5.20
Profit After Tax	2.33	2.61	0.82
EBITDA	3.29	3.65	1.21
NET Worth	8.26	5.35	1.08
Reserves and Surplus	2.95	4.86	0.72
Total Borrowing	4.43	3.86	2.17

Amount in ₹ Crore

IPO Valuation - KPI

KPI	31 Mar 2025
ROCE	36.98%
Debt/Equity Ratio	0.72
Return on Net Worth (RoNW)	48.85%
PAT Margin	16.33%
EBITDA Margin	22.79%
Net Asset Value (NAV)	₹14.72
Earning Per Share (EPS)	₹7.19

Peer Comparison

Company Name	EPS (₹)	P/E (x)	NAV (₹)	RoNW (%)	Income (₹ Cr)
Influx Healthtech Limited	7.31	25.93	5.31	36.72	104.99
Walpar Nutritions Ltd.	1.80	23.94	13.65	11.27	60.26

IPO Anchor Investors

Anchor Investors Letter (PDF)

Promoters and Holding Pattern

Mr. Mayur Popatlal Sojitra, Mr. Ankurkumar Shantilal Patel, Mr. Paraskumar Vinubhai Parmar, Mr. Hardik Mukundbhai Prajapati, Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel are the company's promoters of Accretion Nutraveda.

Particular	Pre IPO	Post IPO
Promoter and Promoter Group	100.00%	73.48%
Others*	0.00%	26.52%

Strengths

Accretion Nutraveda Limited claims to have a product portfolio of over 72 formulations across Ayurvedic and nutraceutical segments. Its manufacturing capabilities span tablets, capsules, oral liquids, churans, oils, and multiple external preparations, covering therapeutic and wellness-focused applications. This range allows it to cater to varied formulation and dosage requirements under a single manufacturing setup.
The company’s manufacturing facility is stated to be WHO-GMP approved and certified under ISO 9001:2015 for its quality management systems and ISO 45001:2018 for occupational health and safety.
The company claims to have built ongoing relationships with clients and suppliers, overseen directly by its promoters. These relationships support the sourcing of raw materials, distribution activities, and operational continuity. Management involvement in these engagements is presented as a key operational feature.
Accretion Nutraveda claims to have formal business processes covering supply chain management, service delivery, and regulatory compliance. Its management and governance framework is stated to support scalability and operations across domestic and export markets.
The company has witnessed a consistent increase in its revenue from operations and profit after tax (PAT). Revenue from operations increased from Rs 2.90 crore in FY23 to Rs 5.00 crore in FY24 and Rs 16.00 crore in FY25. PAT increased from Rs 0.28 crore in FY23 to Rs 0.82 crore in FY24 and Rs 2.61 crore in FY25.

Risks

The top customer accounted for Rs 3.66 crore (26.01 percent) of the company’s total sales for the period ended September 30, 2025; Rs 4.83 crore (30.21 percent) in FY25; Rs 1.26 crore (25.28 percent) in FY24, and Rs 0.44 crore (15.17 percent) in FY23. Any failure to retain this client or negotiate commercially viable long-term contracts, or a reduction in business from them, could adversely affect the company’s revenue, profitability, cash flows, and overall financial condition.
The top supplier accounted for Rs 5.57 crore (55.06 percent) of the company’s total purchase for the period ended September 30, 2025; Rs 4.01 crore (31.38 percent) in FY25; Rs 0.38 crore (9.68 percent) in FY24, and Rs 0.36 crore (13.55 percent) in FY23. Any inability to retain this vendor, negotiate commercially viable terms, or disruption in supplies from them could adversely affect the company’s operations, cost structure, and financial condition.
Gujarat accounted for Rs 13.54 crore (96.28 percent) of the company’s total sales for the period ended September 30, 2025; Rs 14.78 crore (92.34 percent) in FY25; Rs 4.12 crore (82.33 percent) in FY24, and Rs 2.43 crore (83.58 percent) in FY23. Furthermore, the company’s manufacturing facility is also located in this region. Any adverse political, social, regulatory, or economic developments in Gujarat, or an increase in local competition, could negatively impact the company’s business prospects, financial condition, and results of operations.
The company reported negative cash flow from operating activities amounting to Rs 0.89 crore for the period ended September 30, 2025, and Rs 2.21 crore in FY25. This was mainly due to increases in inventories, trade receivables, and other current assets. Additionally, negative cash flow from investing activities amounted to Rs 0.02 crore for the period ended September 30, 2025; Rs 0.87 crore in FY25 and Rs 0.16 crore in FY24, due to capital expenditure for its manufacturing facility. The company also reported negative cash flow from financing activities amounting to Rs 0.04 crore in FY24 and Rs 0.63 crore in FY23. This was due to interest payments and repayment of borrowings. Continued negative operating cash flows or further capex and repayment requirements could constrain liquidity, working capital funding, and future growth.
Accretion Nutraveda is reliant on demand from customers in the nutraceutical industry for a significant portion of its revenue. Any downturn in the nutraceutical industry, loss of nutraceutical customers, or a shift by customers toward developing products in-house could reduce demand for the company’s contract manufacturing services. If competitors or customers develop new products or raw materials that substitute existing offerings, or if competitors achieve lower-cost manufacturing and offer similar products at lower prices, it could adversely affect the company’s revenues and profitability.
The company, its promoters, and group companies are involved in certain ongoing legal proceedings. The company’s business prospects could be hit in case of adverse judgments in any of these cases.
Accretion Nutraveda exports products to Sri Lanka, Singapore, and the US, and its business is exposed to regulatory and compliance requirements in these jurisdictions. Failure to comply with evolving export-market regulations, licensing requirements, or product approval processes could lead to sanctions, enforced shutdowns, delays in approvals, or higher compliance costs, which could adversely affect operations and cash flows. In addition, international transactions can involve geopolitical and economic instability, foreign exchange exposure, longer payment cycles, and difficulty collecting receivables, any of which may adversely affect sales volumes, profitability, and financial condition.
As of September 30, 2025, the company had outstanding financial indebtedness of Rs 4.43 crore. Failure to service or repay these loans could harm the company’s operations and financial position.

Frequently Asked Questions (FAQ)

Comments0

Join the discussion

Please sign in to leave a comment or reply.

Sorted by

Loading IPO Details...

About Accretion Nutraveda IPO

IPO Details

Accretion Nutraveda IPO Details and Specifications
IPO Date	28 Jan 2026 to 30 Jan 2026
Face Value	₹10 Per Share
Price Band	₹122.00 - ₹129.00
Lot Size	1000 Shares
Total Issue Size	Approx 25.00 Cr 19,20,000 Equity Shares
Fresh Issue	Approx 25.00 Cr 19,20,000 Equity Shares
Offer for Sale	Approx 0.00 Cr 0 Equity Shares
Retail Portion	35.09%
Sale Type	Fresh Issue
Issue Type	Bookbuilding IPO
Listing Date	04 Feb 2026
Listing At	BSE
Total Subscription Amount	₹30.24 Cr

Investor Category

Shares Offered

% Net Issue

QIB

9,08,000

49.78%

- Anchor

5,44,000

0.00%

- QIB (Ex. Anchor)

3,64,000

0.00%

NII

2,76,000

15.13%

- bNII > ₹10L

1,84,000

0.00%

- sNII < ₹10L

92,000

0.00%

Retail

6,40,000

35.09%

Total

18,24,000

100.00%

Application

Lots

Amount

Individual investors (Retail) (Min)

2,000

₹2,58,000

Individual investors (Retail) (Max)

2,000

₹2,58,000

S-HNI (Min)

3,000

₹3,87,000

S-HNI (Max)

7,000

₹9,03,000

B-HNI (Min)

8,000

₹10,32,000

About Company

Contact Details

Accretion Nutraveda Ltd.

27 Xcelon Industrial Park-1

Vasna-Chacharwadi, TaSanand,

Ahmedabad, Gujarat, 382213

+91- 9904366177

compliance@accretionnutraveda.com

Visit Website

Date & Time

GMP (₹)

Est. Listing Price

Est. Gain (%)

Est. Profit / Lot (₹)

04-Feb-2026 12:00 AM

+₹16

₹145

+12.40%

₹16,000

03-Feb-2026 12:00 AM

+₹16

₹145

+12.40%

₹16,000

02-Feb-2026 12:00 AM

+₹6

₹135

+4.65%

₹6,000

01-Feb-2026 12:00 AM

+₹4

₹133

+3.10%

₹4,000

31-Jan-2026 12:00 AM

+₹4

₹133

+3.10%

₹4,000

30-Jan-2026 05:05 PM

+₹0

₹129

+0.00%

₹0

29-Jan-2026 02:45 PM

+₹0

₹129

+0.00%

₹0

28-Jan-2026 03:45 PM

+₹0

₹129

+0.00%

₹0

27-Jan-2026 03:45 PM

+₹0

₹129

+0.00%

₹0

26-Jan-2026 01:00 PM

+₹0

₹129

+0.00%

₹0

24-Jan-2026 03:45 PM

+₹0

₹129

+0.00%

₹0

23-Jan-2026 02:52 PM

+₹0

₹129

+0.00%

₹0

22-Jan-2026 03:45 PM

+₹0

₹129

+0.00%

₹0

21-Jan-2026 03:45 PM

+₹0

₹129

+0.00%

₹0

20-Jan-2026 03:45 PM

+₹0

₹129

+0.00%

₹0

Accretion Nutraveda IPO Details

About Accretion Nutraveda IPO

IPO Details

Issue Reservation

IPO Lot Size

About Company

Day-wise GMP Trend

Objects of the Issue

Company Financials

IPO Valuation - KPI

Peer Comparison

IPO Anchor Investors

Promoters and Holding Pattern

Strengths

Risks

Frequently Asked Questions (FAQ)

When does the Accretion Nutraveda IPO open and close?

What is Accretion Nutraveda IPO price band?

What is the Accretion Nutraveda IPO lot size?

What is the Accretion Nutraveda IPO allotment date?

What is the Accretion Nutraveda IPO listing date?

What is the minimum investment required in Accretion Nutraveda IPO?

Join the discussion

Accretion Nutraveda IPO Details

About Accretion Nutraveda IPO

IPO Details

Issue Reservation

IPO Lot Size

About Company

Day-wise GMP Trend

Objects of the Issue

Company Financials

IPO Valuation - KPI

Peer Comparison

IPO Anchor Investors

Promoters and Holding Pattern

Strengths

Risks

Frequently Asked Questions (FAQ)

When does the Accretion Nutraveda IPO open and close?

What is Accretion Nutraveda IPO price band?

What is the Accretion Nutraveda IPO lot size?

What is the Accretion Nutraveda IPO allotment date?

What is the Accretion Nutraveda IPO listing date?

What is the minimum investment required in Accretion Nutraveda IPO?

Join the discussion